Anaphylaxis and other adverse reactions to blue dyes: A case series

Anaesthesia and Intensive Care

Volumn 39, Issue 2, 2011, Pages 287-292

  Howard, J D ^a   Moo, V ^a   Sivalingam, P ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Anaesthesia; Anaphylaxis; Patent blue V dye

Indexed keywords

ADRENALIN; ATROPINE; CEFAZOLIN; CELECOXIB; CISATRACURIUM; DEXAMETHASONE; EVANS BLUE; FENTANYL; HYDROCORTISONE; METARAMINOL; METHOTREXATE; MIDAZOLAM; MORPHINE; PANTOPRAZOLE; PENICILLIN G; PETHIDINE; PROMETHAZINE; PROPOFOL; RAMIPRIL; SALAZOSULFAPYRIDINE; SEVOFLURANE; TELMISARTAN;

ADULT; ALLERGIC REACTION; ALLERGY; ANAPHYLAXIS; ANESTHESIA; ANGIONEUROTIC EDEMA; ARTICLE; BRADYCARDIA; BREAST LESION; BRONCHOSPASM; CASE REPORT; CRYSTALLOID; DRUG ERUPTION; ENDOTRACHEAL INTUBATION; FEMALE; FLUID THERAPY; FLUSHING; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION; INTRACUTANEOUS TEST; MALE; MEDICAL INFORMATION; PRURITUS; PULSE OXIMETRY; SENTINEL LYMPH NODE; SIDE EFFECT; SKIN TEST; URTICARIA;

EID: 79953202553     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1103900221     Document Type: Article

References (36)

1. Hill A, Tran K, Akhurst T, Yeung H, Yeh S, Rosen P et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229:528-535. (Pubitemid 30191751)
2. Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822. (Pubitemid 26406231)
3. Syme DBY, Collins JP, Mann GB. Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy. ANZ J Surg 2005; 75:817-821. (Pubitemid 43942672)
4. Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lympazurin in breast cancer sentinel node mapping. Am J Surg 2002; 184:341-345. (Pubitemid 35287355)
5. Simmons RM, Rosenbaum Smith, SM, Osborne MP. Methylene blue as an alternative to isosulfan blue for sentinel lymph node localization. The Breast Journal 2001; 7:181-183. (Pubitemid 32619780)
6. ADRAC. Patent blue V and anaphylaxis. Aust Adv Drug React Bull 2002; 21:10.
7. Sprung J, Tully MJ, Ziser A. Anaphylactic reactions to isosulfan blue dye during sentinel node lymphadenectomy for breast cancer. Anesth Analg 2003; 96:1051-1053. (Pubitemid 36359041)
8. Efron P, Knudsen E, Hirshorn S, Copeland EM. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. The Breast Journal 2002; 8:396-399. (Pubitemid 35334660)
9. Montgomery L, Thorne A, Van Zee K, Fey J, Heerdt A, Gemignani M et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002; 95:385-388. (Pubitemid 34793105)
10. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001; 182:393-398. (Pubitemid 33079094)
11. Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001; 130:439-442.
12. Leong SPL, Donegan E, Hefernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000; 7:361-366. (Pubitemid 30397478)
13. Sadiq TS, Burns WW 3rd, Taber DJ, Damitz L, Ollila DW. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg 2001; 136:1433-1435. (Pubitemid 33117053)
14. Kuerer HM, Hunt KK, Singletary SE, Ames FC. Unusual aspects of breast cancer: case 3 - blue hives during lymphatic mapping for breast cancer. J Clin Oncol 2001; 19:2573-2574.
15. Scherer K, Bircher A, Figueiredo V. Blue dyes in medicine - a confusing terminology. Contact Dermatitis 2006; 54:231-232.
16. Scherer K, Studer W, Figueiredo V, Bircher A. Anaphylaxis to isosulfan blue and cross reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006; 96:497-500.
17. Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P. Australia incidence monitoring study - clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21:621-625.
18. Daley MD, Norman PH, Leak JA, Nguyen DT, Bui TP, Kowalski AM et al. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth 2004; 16:332-341. (Pubitemid 39221470)
19. Keller B, Yawalkar N, Pichler C, Braathen LR, Hunger RE. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients. Am J Surg 2007; 193:122-124.
20. Hunting AS, Nopp A, Johansson SGO, Andersen F, Wilhelmsen V, Guttormsen AB. Anaphylaxis to patent blue V. I. Clinical aspects. Allergy 2010; 65:117-123.
21. Mertes PM, Malinovsky JM, Mouton-Faivre C, Bonnet-Boyer MC, Benhaijoub A, Lavaud F et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 2008; 122:348-352.
22. Newton DW, Breen PJ, Brown DE, Mackie JF Jr, Kluza RB. Physicochemical characteristics of patent blue violet dye. J Pharm Sci 1981; 70:122-127.
23. Coleman RL, Whitten CW, O'Boyle J, Sidhu B. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (Isosulfan Blue) during a lymphatic mapping procedure. J Surg Oncol 1999; 70:126-129. (Pubitemid 29108827)
24. Scheller MS, Unger RJ, Kelner MJ. Effects of intravenously administered dyes on pulse oximetry readings. Anesthesiology 1986; 65:550-552. (Pubitemid 17183885)
25. El-Tamer M, Komenaka I, Curry S, Troxel A, Ditkoff B, Schnabel FR. Pulse oximeter changes with sentinel lymph node biopsy in breast cancer. Arch Surg 2003; 138:1257-1260. (Pubitemid 37392405)
26. Koivusalo AM, Von Smitten K, Lindgren L. Sentinel node mapping affects intraoperative pulse oximetric recordings during breast cancer surgery. Acta Anaesthesiol Scand 2002; 46:411-414. (Pubitemid 34454437)
27. Kieckbusch H, Coldeway S, Hollenhorst J, Haeseler G, Hillemanns P, Hertel H. Patent blue sentinel node mapping in cervical cancer patients may lead to decreased pulse oximeter readings and positive methaemoglobin results. Eur J Anaesthesiol 2008; 25:365-368.
28. Burgoyne LL, Jay DW, Bikhazi GB, De Armendi AJ. Isosulfan blue causes factitious methemoglobinaemia in an infant. Paediatr Anaesth 2005; 15:1116-1119. (Pubitemid 43965393)
29. Wöhrl S, Focke M, Hinterhuber G, Stingl G, Binder M. Near fatal anaphylaxis to patent blue V. Br J Dermatol 2004; 150:1037-1038.
30. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. BJA 1998; 80:26-29. (Pubitemid 28029719)
31. Brown SA, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emergency Medicine Australasia 2004; 16:120-124.
32. Raut CP, Hunt KK, Akins JA, Ross MI, Singletary SE, Marshall GD et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis. Cancer 2005; 104:692-699. (Pubitemid 41113667)
33. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005; 189:236-239. (Pubitemid 40255120)
34. Nour A. Efficacy of methylene blue dye in localisation of sentinel lymph node in breast cancer patients. The Breast Journal 2004; 10:388-391. (Pubitemid 39281309)
35. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? The Breast Journal 2006; 12:428-430.
36. Pinero A, Illana J, Garcia-Palenciano C, Canizares F, Canteras M, Canadillas V. Effect on oximetry of dyes used for sentinel lymph node biopsy. Are there differences? Arch Surg 2004; 139:1204-1207. (Pubitemid 39463454)